Aaron Glenn Louis Fletcher
Independent DirectorDr. Aaron Glenn Louis Fletcher, Ph. D., serves as a Director at ONL Therapeutics, Inc. and serves as its Chairman since August 2026. Dr. Fletcher is Independent Chairman at Actuate Therapeutics, Inc. and has been its Independent Director since April 2015. He serves as a Principal of Bios Equity COF, LP, Issuer of Bios 2026 Co-Invest, LP. He was Chairman of the Board of TFF Pharmaceuticals, Inc. since December 2018 until November 2023 and served as its Director since March 2018 until November 2023. He serves as Principal of Bios Equity COF, LP & Director of Bios Clinical Opportunity Fund, Lp. He served as a Director of Cue Biopharma, Inc. since October 3, 2019 until October 9, 2023. In 2012, Dr. Fletcher founded Bios Research, LLC and has served as its President since 2012. Since 2014, Dr. Fletcher serves as Managing Partner of Bios Partners, LP. having founded it in 2014. Dr. Fletcher served as a Director of Lung Therapeutics until October 2023 and He served as Director of AbiliTech Medical, Inc. since November 2016 until January 2023 and Actuate Therapeutics, Inc. since January 2015, where he serves as its Chairman. Dr. Fletcher serves as Independent Director of Cognition Therapeutics, Inc. since July 2015. Dr. Fletcher has worked as an Independent Consultant for the biotech/healthcare equity industry for over ten years. He served as an Independent Director at SWK Holdings Corporation since August 30, 2019 until December 31, 2021. He serves as Director of LTI since August 2014. Dr. Fletcher has also served as a professor at Dallas Baptist University since 2008, where he teaches biochemistry, bioethics and cell biology. Dr. Fletcher also serves as Director of Acute Therapeutics. Dr. Fletcher holds a Ph. D. in Biochemistry from Colorado State University. Dr. Fletcher holds a BS in Biology from York College.
Positions
- Company NameCognition Therapeutics, Inc.Stock CodeCGTXPositionIndependent DirectorColleagues
- LRLisa RicciardiCEO, President & Director
- JAJack A. KhattarIndependent Chairman of the Board
- JBJohn Brendan DoyleChief Financial Officer
- AOAnthony O. CaggianoChief Medical Officer
- SASteven A. WeissmanVP & Head of CMC
- ACAnita CornetHead of Quality
- EBEllen B. RichstoneIndependent Director
- MGMichael GrundmanMember of Medical Advisory Board
- Company NameActuate Therapeutics, Inc.Stock CodeACTUPositionIndependent ChairmanColleagues
- DMDaniel M. SchmittCEO, President & Director
- AGAaron Glenn Louis FletcherIndependent Chairman
- APAndrew P. MazarCo-Founder & COO
- PJPaul J. LytleChief Financial Officer
- AKAlan KozikowskiScientific Founder and Advisor
- DLDaniel L. ZabrowskiIndependent Director
- JAJason A. KeyesIndependent Director
- RBRoger B. CohenMember of Scientific Advisory Board
